Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® ...

Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

ioTracker Cells, the new range within bit.bio's ioCells portfolio, deliver added visualisation capabilities that enhance the portfolio of deterministically-programmed human iPSC-derived cells powered ...

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today the opening of its ...

Between an afternoon retreat and regular Monday night meeting, the district and board were busy with handfuls of future ...

A new analysis of 2023 data conducted by the Indiana Primary Health Care Association (IPHCA) and Capital Link, highlights the transformative impact Community Health Centers have on Indiana's health ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.